Impact of old environmental burden in the Spis region (Slovakia) on soil and home-grown vegetable contamination, and health effects of heavy metals.

Due to several centuries of ongoing mining activities, Middle Spis (Slovakia) is one of the areas with a damaged environment. The contents of Fe, Mn, Zn, Cu, Ni, Pb, Cd, and Hg were determined in the soils and home-grown vegetables (potatoes, carrots, tomatoes). Except for Pb, the contents of heavy metals in the soils of some plots were higher than the limit values. Based on the values of Contamination factor (Cf), Degree of contamination (Cdeg), Geo-accumulation index (Igeo), and Pollution load index (PLI), very high Fe, Cd, and Hg contamination (Cf ≥ 6), very high soil contamination (Cdeg ≥ 20), extremely heavy Fe and Hg contamination (Igeo > 5), resp. moderately pollution to non-pollution (1 < PLI ≤ 2) was found in all plots. In vegetable samples, the maximum levels were exceeded for Cu, Pb, Hg (potato), Pb (carrot, tomato), and Hg (carrot, plot E). Bioaccumulation factor values BAF > 1 were for Cu (carrots, potatoes). Estimated daily intake values for all heavy metals were lower than their tolerable daily intake. Chronic daily intake of heavy metals ranged 2.495E-06 (Hg)-0.1416 (Fe) mg/kg/day. Based on Hazard index values, potato consumption poses a risk (0.8068-1.3057). The results showed that the monitoring of soils and cultivated production is necessary for the investigated area.

Changes in Antioxidant Properties and Phenolics in Sweet Potatoes (Ipomoea batatas L.) Due to Heat Treatments.

Processing is one of the most crucial factors affecting polyphenol content in foods. Therefore, the study is aimed at the evaluation of heat treatment effects (microwaving, steaming, baking, and boiling) on the content of chlorogenic acids, total polyphenols, and antioxidant activity of three varieties of sweet potato with different flesh colors (Beauregard­orange-fleshed, O'Henry­white-fleshed, 414-purple­purple-fleshed). According to high performance liquid chromatography analysis, chlorogenic acid was the predominant chlorogenic acid in sweet potatoes. Obtained results also suggested the purple-fleshed variety (414-purple) had significantly (p < 0.05) higher total polyphenol content and thus the highest antioxidant activity. Heat treatment positively influenced the chlorogenic acid content, total polyphenols, and antioxidant activity of sweet potatoes. Among the used methods, steaming had the greatest effect on the chlorogenic acids and total polyphenols, while microwaved samples showed the highest antioxidant activity (DPPH). The content of chlorogenic acids and total polyphenols decreased in the order of steaming > baking > microwaving > boiling > raw. However, the individual varieties differed not only in the flesh color but also in the reaction to the used heat treatment methods. Spearman's correlation coefficient showed a strong correlation between chlorogenic acid and antioxidant activity.

Seroprevalence of Measles Antibodies in the Population of the Olomouc Region, Czech Republic-Comparison of the Results of Four Laboratories.

OBJECTIVES: Although the incidence of measles has decreased globally since the introduction of regular vaccination, its frequency has increased again in recent years. The study is focused on data from the Olomouc Region in the Czech Republic analyzed in four laboratories. The obtained results were compared with already published data. METHODS: The data were provided by individual laboratories in an anonymized form-age at the time of the examination, sex, and result of test. Samples were collected between June 2018 and September 2019 and evaluated on the scale positive-borderline-negative. RESULTS: A total of 7962 sera samples were evaluated using three different methods-two types of ELISA tests and CLIA. Positive result was issued in a total of 62.6 percent of samples, but the results of individual laboratories varied widely from 55.5 to 70.8 percent. However, the same trend with the highest levels of antibodies in people born before beginning of vaccination was observed. CONCLUSIONS: Data show significantly different results depending on the individual laboratories and the detection kits used. The underestimation of the proportion of positive results can cause problems in selecting individuals for revaccination with a live vaccine, which may fail in weakly positive individuals.

Mercury in Macrolepiota procera (Scop.) Singer and Its Underlying Substrate-Environmental and Health Risks Assessment.

Wild-growing edible mushrooms are valuable food with a high content of proteins, fibers, antioxidants, and they are characterized by their specific taste and flavor. However, from an ecotoxicological point of view, they are a risk commodity because of their extremely high bioaccumulative capacity to accumulate the risk elements and contaminants from the environment. In the present study, we examined mercury (Hg) contamination in 230 fruiting bodies of Macrolepiota procera (Scop.) Singer and 230 soil/substrate samples, which were collected in foraging seasons 2015-2019 from 22 different locations in Slovakia. Total mercury content was determined by cold-vapor AAS analyzer AMA 254. The level of contamination and environmental risks were assessed by contamination factor (Cf), index of geoaccumulation (Igeo), and potential environmental risk index (PER). Bioaccumulation factor (BAF) was calculated for individual anatomical parts of M. procera. Mercury content in the soil/substrate samples varied between 0.02 and 0.89 mg kg-1 DW, and in mushroom samples between 0.03 and 2.83 mg kg-1 DW (stems), and between 0.04 and 6.29 mg kg-1 DW (caps). The obtained results were compared with the provisional tolerable weekly intake for Hg defined by WHO to determine a health risk resulting from regular and long-term consumption of M. procera.

Hygienic quality of soil in the Gemer region (Slovakia) and the impact of risk elements contamination on cultivated agricultural products.

The Gemer region (Slovakia) belongs to areas with a high concentration of risk elements. The contents of Cu, Ni, Pb, Cd, Hg and Mn were determined in soils and cultivated agricultural production from lands in three cadastres of the Gemer region (Henckovce (48.713845, 20.426189) and Nizná Slaná (48.717373, 20.4208423), cultivated crop-spring triticale; Gemerská Poloma (48.704523, 20.487645), cultivated crop-maize). Bioavailable forms of Pb (0.306-0.532 mg/kg) and Cd (0.104-0.154 mg/kg), pseudototal forms of Cd (3.07-3.98 mg/kg) and Hg (0.484-2.18 mg/kg) represented the highest risk in soils. The highest contents of Pb (Cd, Hg) were in maize from Gemerská Poloma: 0.898 (0.081, 0.399) mg/kg DM. Soils were classified based on several indicators of soil contamination. The highest values of indicators are: Contamination factor (Cf 29.1-Hg), Degree of contamination (Cdeg 51.5), Potential ecological risk factor (Er 1163-Hg), Potential ecological risk index (RI 1,520), Pollution load index (PLI 4.76), Geo-accumulation index (Igeo 5.60-Hg). All indicators concerned the lands of Henckovce and Gemerská Poloma, RI also concerned the land of Nizná Slaná. Bioaccumulation factor (BAF) was calculated to assess the plant's ability to absorb the risk element. For both crops and all risk elements, BAF values were < 1. Obtained results indicate heavy metal contamination of soils, therefore monitoring of soils in investigated area is necessary.

Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies.

INTRODUCTION: Real-world data on patient outcomes and treatment patterns in multiple myeloma (MM) are limited. MATERIALS AND METHODS: The present noninterventional, observational, retrospective analysis of prospectively collected Czech patient medical record data from the Registry of Monoclonal Gammopathies estimated real-world outcomes in adults with a diagnosis of symptomatic MM made between May 2007 and June 2014. RESULTS: In total, 2446 patients had initiated first-line treatment. The median overall survival since the diagnosis (primary endpoint) was 50.3 months (95% confidence interval, 46.1-54.5 months) and decreased with each successive treatment line. A similar trend was observed for progression-free survival and the depth of response. In line with European guidelines and clinical practice, bortezomib-, thalidomide-, and lenalidomide-based regimens were most commonly used across all treatment lines (42.3%, 28.9%, and 18.4%, respectively). In the first line, bortezomib and thalidomide were used most often, with lenalidomide the most commonly used agent in the relapse setting (second to fourth lines). Exploratory analyses revealed that younger age (≤ 65 years), lower international staging system stage, and previous stem cell transplantation were associated with significant improvements in overall and progression-free survival, especially in the early treatment lines. CONCLUSION: The present study is the first analysis of Czech data from the Registry of Monoclonal Gammopathies, and it provides important insights into the real-world management of MM for physicians and healthcare providers.

Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients.

OBJECTIVES: We conducted an adjusted comparison of progression-free survival (PFS) and overall survival (OS) for daratumumab monotherapy versus standard of care, as observed in a real-world historical cohort of heavily pretreated multiple myeloma patients from Czech Republic. METHODS: Using longitudinal chart data from the Registry of Monoclonal Gammopathies (RMG) of the Czech Myeloma Group, patient-level data from the RMG was pooled with pivotal daratumumab monotherapy studies (GEN501 and SIRIUS; 16 mg/kg). RESULTS: From the RMG database, we identified 972 treatment lines in 463 patients previously treated with both a proteasome inhibitor and an immunomodulatory drug. Treatment initiation dates for RMG patients were between March 2006 and March 2015. The most frequently used treatment regimens were lenalidomide-based regimens (33.4%), chemotherapy (18.1%), bortezomib-based regimens (13.6%), thalidomide-based regimens (8.0%), and bortezomib plus thalidomide (5.3%). Few patients were treated with carfilzomib-based regimens (2.5%) and pomalidomide-based regimens (2.4%). Median observed PFS for daratumumab and the RMG cohort was 4.0 and 5.8 months (unadjusted hazard ratio [HR], 1.14; 95% confidence interval [CI], 0.94-1.39), respectively, and unadjusted median OS was 20.1 and 11.9 months (unadjusted HR, 0.61; 95% CI, 0.48-0.78), respectively. Statistical adjustments for differences in baseline characteristics were made using patient-level data. The adjusted HRs (95% CI) for PFS and OS for daratumumab versus the RMG cohort were 0.79 (0.56-1.12; p = .192) and 0.33 (0.21-0.52; p < .001), respectively. CONCLUSIONS: Adjusted comparisons between trial data and historical cohorts can provide useful insights to clinicians and reimbursement decision makers on relative treatment efficacies in the absence of head-to-head comparison studies for daratumumab monotherapy.